Design, synthesis and biological evaluation of novel 2-methylpyrimidine-4-ylamine derivatives as inhibitors of Escherichia coli pyruvate dehydrogenase complex E1.
As potential inhibitors of Escherichia coli pyruvate dehydrogenase complex E1 (PDHc E1), a series of novel 2-methylpyrimidine-4-ylamine derivatives were designed based on the structure of the active site of PDHc E1 and synthesized using 'click chemistry'. Their inhibitory activity in vitro against PDHc E1 and fungicidal activity were examined. Some of these compounds such as 3g, 3l, 3n, 3o, and 5b demonstrated to be effective inhibitors of PDHc E1 from E. coli and exhibited antifungal activity. SAR analysis indicated that both, the inhibitory potency against E. coli PDHc E1 and the antifungal activity of title compounds, could be increased greatly by optimizing substituent groups in the compounds. The structures of substituent group in 5-position on the 1,2,3-triazole and 4-position on the benzene ring in title compounds were found to play a pivotal role in both above-mentioned biological activities. Amongst all the compounds, compound 5b with iodine in the 5-position of 1,2,3-triazole and with nitryl group in the 4-position of benzene ring acted as the best inhibitor against PDHc E1 from E. coli. It was also found to be the most effective compound with higher antifungal activity against Rhizoctonia solani and Botrytis cinerea at the dosage of 100 μg mL(-1). Therefore, in this study, compound 5b was used as a lead compound for further optimization.
Key Laboratory of Pesticide & Chemical Biology, Ministry of Education, Department of Chemistry, Central China Normal University, Wuhan, China.
Junbo
J
He
Lingling
L
Feng
Jing
J
Li
Ruijuan
R
Tao
Fang
F
Wang
Xun
X
Liao
Qiushuang
Q
Sun
Qingwu
Q
Long
Yanliang
Y
Ren
Jian
J
Wan
Hongwu
H
He
D000588:Amines / Q000138:chemical synthesis / Q000737:chemistry / Q000494:pharmacology*; D020134:Catalytic Domain; D057930:Click Chemistry; D004791:Enzyme Inhibitors / Q000138:chemical synthesis / Q000737:chemistry* / Q000494:pharmacology*; D004926:Escherichia coli / Q000187:drug effects / Q000201:enzymology*; D020128:Inhibitory Concentration 50; D056004:Molecular Dynamics Simulation; D011743:Pyrimidines / Q000138:chemical synthesis / Q000737:chemistry / Q000494:pharmacology*; D030481:Pyruvate Dehydrogenase (Lipoamide) / Q000037:antagonists & inhibitors* / Q000737:chemistry / Q000378:metabolism
D000588:Amines; D004791:Enzyme Inhibitors; D011743:Pyrimidines; D030481:Pyruvate Dehydrogenase (Lipoamide)